A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
National Cancer Institute (NCI)
Beijing Biotech
OncoC4, Inc.
Jazz Pharmaceuticals
Bayer
Exscientia AI Limited
Seagen Inc.
Alliance for Clinical Trials in Oncology
Conjupro Biotherapeutics, Inc.
AstraZeneca
Aulos Bioscience, Inc.
Arcus Biosciences, Inc.
Sotio Biotech Inc.
858 Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Imperial College London
GlaxoSmithKline
SystImmune Inc.
Rondo Therapeutics
AstraZeneca
BeOne Medicines
Psyence Australia Pty Ltd
Neonc Technologies, Inc.
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Essen Biotech
BioNTech SE
Brigham and Women's Hospital
Poseida Therapeutics, Inc.
Baylor College of Medicine
MacroGenics
Genentech, Inc.
xCures
Daiichi Sankyo
University of Nebraska
Takeda
Cue Biopharma
Adela, Inc
Second Life Therapeutics
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Innate Pharma
Dren Bio
Var2 Pharmaceuticals